E. coli |
P678-54 treated with triethylenemelamine (0.5 mg/ml) |
Basic properties of E. coli minicells |
38 |
BS100(λDB173), a min mutant |
Z-ring formation is associated with minicell formation |
106 |
Minicell mutant X-1488 (F−
str hst hsm+
minA minB purE pdxC his ile met ade ura [r− mK+]) |
Identification of membrane proteins enriched in minicells |
107 |
WM3433 (ΔminCDE::kan introduced into DS612 [mreB-A125V linked to yhdE::cat]) |
In situ structural studies of phage P1 infection |
61 |
WM4011 (pBAD30-flhDC in WM3433 with ΔclpX::kan fadR::Tn10) |
In situ structural studies of receptor arrays, phage adsorption, and DNA translocation |
66, 88, 90, 92
|
B. subtilis |
CV403 + divIVBI mutant |
Gram-positive minicell production and properties |
55 |
|
Molecular transport |
108 |
|
Bacteriophage-directed polypeptide synthesis |
109 |
C. glutamicum |
parA ΔNCgl1366 |
Drug delivery system |
40 |
Haemophilus influenzae |
LB11 mutagenesis with N-methyl-N′-nitro-N-nitrosoguanidine |
Phage induction |
110 |
L. monocytogenes |
ΔminCDE mutant |
Drug delivery system |
39 |
P. aeruginosa |
ΔminCDE mutant |
Drug delivery system |
39 |
S. enterica |
TH17261 ParaBAD1091::ftsZ+
|
In situ structure of chemoreceptor array |
65 |
SJW1103/pBAD24-ftsZ
|
In situ structure of injectisome and flagellum |
75 |
SL1344 minD::cat
|
Minicell virulence |
41 |
S. flexneri |
M90T-Sm/pB558 (E. coli
ftsQAZ genes) |
In situ structure of injectisome |
78 |
Y. enterocolitica |
Y. enterocolitica E40 × E. coli Sm10λpir+ (BW19610) |
In situ structure of injectisome |
77 |